BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
94 hedge funds and large institutions have $891M invested in BELLUS Health Inc. in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 8 closing their positions.
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
150% more funds holding in top 10
Funds holding in top 10: 4 → 10 (+6)
88% more call options, than puts
Call options by funds: $2.57M | Put options by funds: $1.37M
33% more capital invested
Capital invested by funds: $672M → $891M (+$219M)
21% more funds holding
Funds holding: 78 → 94 (+16)
25% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$32.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$14M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.8M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.23M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$21.3M |
| 2 |
AG
Artal Group
Luxembourg
|
-$12.3M |
| 3 |
DM
Deerfield Management
New York
|
-$9.81M |
| 4 |
CC
Commodore Capital
New York
|
-$9.47M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$6.21M |
BLU Hedge Fund Activity: Q2 2022 in Review
94 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q2 2022, worth a combined $891M — up 33% from $672M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new BLU positions and 8 closed out — a net gain of 16 holders — while 24 added to existing stakes and 32 trimmed.
The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $32.3M. The largest seller was Perceptive Advisors, cutting an estimated $21.3M.
- 94 institutional investors held BELLUS Health Inc. (BLU) as of Q2 2022, up from 78 in Q1 2022.
- Funds reported $891M of BELLUS Health Inc. stock for Q2 2022, up 33% quarter-over-quarter.
- 24 funds opened new BELLUS Health Inc. positions in Q2 2022 and 8 closed out, a net change of +16 holders.
- The largest BELLUS Health Inc. buyer in Q2 2022 was Pictet Asset Management (Switzerland), an estimated $32.3M added.
- The largest BELLUS Health Inc. seller in Q2 2022 was Perceptive Advisors, an estimated $21.3M sold.
Based on aggregated 13F filings for Q2 2022.